SESSION 23 SCHEDULE
Wednesday
SESSION 23: TOPICS RELATED TO GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE LESIONS
Location: Grand Ballroom East, 3rd Floor
Moderators:Enrico Ascher, MD / Craig M. Walker, MD  
x
6:40 AM - 6:45 AM Status Of The Global Vascular Guideline For The Treatment Of CLTI And The Global Limb Anatomic Staging System: How Will They Help
  Presenter(s):Michael S. Conte, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
6:46 AM - 6:51 AM How Have Drug Delivery (Coating) And Retrograde Access Changed The Paradigm For SFA/Pop Treatment: The Game Has Changed
  Presenter(s):Peter A. Schneider, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
6:52 AM - 6:57 AM The Class Effect vs. The Specific Device Effect Of Drug Eluting Devices And Other Treatments For Arterial Occlusive Lesions: Why Is The Difference Important
  Presenter(s):Thomas Zeller, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
6:58 AM - 7:03 AM DEBATE: In The Near Future Almost All Lower Extremity Treatment For Occlusive Lesions Will Be Endovascular And Endo-First Will Be The Rule
  Presenter(s):Craig M. Walker, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
7:04 AM - 7:09 AM DEBATE: Not So: Many Patients Will Be Better Served By A Bypass At Some Point In Their Course, And Some With A Bypass As Their Primary Procedure
  Presenter(s):Joseph L. Mills, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
7:10 AM - 7:15 AM Overuse Of Endo-First Treatment For CLTI With Tissue Necrosis Jeopardizes Last Chance Bypasses And Limb Salvage
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
7:16 AM - 7:21 AM Importance Of Adequate Vessel Prep Before Stenting And DCBs: How Best To Do It And Proof Of Its Value
  Presenter(s):D. Christopher Metzger, MD   
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
7:22 AM - 7:27 AM Value Of Local Anesthesia In The Adventia Of Arteries During Interventions: How To Do It: For SFA/Pop Lesions
  Presenter(s):Andrej Schmidt, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
7:28 AM - 7:33 AM Optimal Current Treatment For SFA/Pop Occlusive Lesions: What Technology Is Best And When
  Presenter(s):Gary M. Ansel, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
7:34 AM - 7:39 AM Below The Ankle (BTA) PTA: When Is It Helpful: When Harmful: Should 1 Or More Arteries Be Treated; Other Pearls
  Presenter(s):Roberto Ferraresi, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
7:40 AM - 7:46 AM Panel Discussion
END OF SESSION 23
 
SESSION 24 SCHEDULE
Wednesday
SESSION 24: PROGRESS IN LOWER EXTREMITY STENT BASED TREATMENTS FOR OCCLUSIVE LESIONS
Location: Grand Ballroom East, 3rd Floor
Moderators:Frank J. Veith, MD / Dierk Scheinert, MD  
x
7:46 AM - 7:51 AM Optimal Treatment For Crural Artery Lesions In 2018 In The US And Elsewhere: Value Of Coronary Drug Eluting Stents (DESs): When And How To Use Them
  Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
7:52 AM - 7:57 AM Endovascular Stent Treatment Of Common Femoral Artery (CFA) Is Best For All Lesions: Based On The TECCO RCT (Stent vs. Open Endarterectomy): Classification Of Lesions And Subsequent Access Through Stents Is OK
  Presenter(s):Yann Gouëffic, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
7:58 AM - 8:03 AM Value Of Multiple Short Stents For Treating Fempop Long Lesions: Better Than A Full Metal Jacket: The LOCOMOTIVE Trial Of Vascuflex System (From B. Braun)
  Presenter(s):Thomas Zeller, MD / Peter C.J. Goverde, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:04 AM - 8:09 AM New Findings From The Zilver PTX DES 5-Year RCT And Other Studies Show The Advantages Of This Stent For Fempop Lesions
  Presenter(s):Michael D. Dake, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:10 AM - 8:15 AM Value And Limitations Of Zilver PTX DESs: How Do They Change The Pattern And Volume Of In-Stent Restenosis (ISR) Compared To Other Stents
  Presenter(s):Gary M. Ansel, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:16 AM - 8:21 AM ZILVER PASS RCT Comparing ZILVER PTX DES To PTFE Fempop Bypasses: For TASC C And D Lesions: Zilver PTX Is As Good Or Better At 2 Years
  Presenter(s):Marc Bosiers, MD / Koen R. Deloose, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:22 AM - 8:27 AM 2-Year Results Of The RAPID RCT Comparing Supera Stent Treatment For SFA Lesions With And Without A DCB
  Presenter(s):Jean-Paul de Vries, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:28 AM - 8:33 AM MAJESTIC DES Trial: 3-Year Results For Treatment In Superficial Femoral And Proximal Popliteal Lesions: How Does Eluvia Differ From Other DES
  Presenter(s):Stefan Mueller-Huelsbeck, MD / Thomas Zeller, MD / Dierk Scheinert, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:33 AM - 8:38 AM IMPERIAL Head To Head RCT: 1 Year Results Of The Eluvia DES vs. ZilverPTX For Fempop Lesions
  Presenter(s):William A. Gray, MD / Andrew Holden, MBChB  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:39 AM - 8:44 AM Status Of Bioresorbable DESs For Treating BTK Arteries: Though They Failed In The Coronary Arteries They Show Promise In The Leg: The ABSORB BTK Trial 4-Year Results Show Why
  Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
8:45 AM - 8:58 AM Panel Discussion
END OF SESSION 24
 
SESSION 25 SCHEDULE
Wednesday
SESSION 25: MORE TOPICS RELATED TO COMPLEX LOWER EXTREMITY DISEASE AND ITS TREATMENT: ATHERECTOMY, LITHOPLASTY, OVERCOMING CALCIFICATION BELOW THE KNEE (BTK), TIBIAL ARTERY TREATMENTS, AND COMBINATIONS OF TREATMENTS
Location: Grand Ballroom East, 3rd Floor
Moderators:Joseph L. Mills, MD / Barry T. Katzen, MD  
x
8:58 AM - 9:03 AM Atherectomy 2018: When Indicated; Which Device(s) Are Best; Downsides; Precautions; Are Complementary DCBs Necessary
  Presenter(s):Lawrence A. Garcia, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:04 AM - 9:09 AM Histological Evaluation Of Adventitial Injury From Directional Atherectomy: Value Of OCT Guidance
  Presenter(s):Theodosios Bisdas, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:10 AM - 9:15 AM Debulking Atherectomy: Is There Proof It Has Value: In What Circumstances: Which Device Is Best And Why
  Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:16 AM - 9:21 AM Importance Of Debulking And Other Lesion Preparation Strategies With All Drug Eluting Treatments: Why It Is Critical
  Presenter(s):Erwin Blessing, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:22 AM - 9:27 AM Value Of Intravascular Lithotripsy (Shockwave Medical) With And Without DCBs For Treatment Of Calcified Lesions: Single Center Studies And The DISRUPT I, II And III Trial Results
  Presenter(s):Gunnar Tepe, MD / Andrew Holden, MBChB / Thomas Zeller, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
BTK TREATMENTS
9:28 AM - 9:33 AM Present And Future Status Of DCBs: Successes, Failures, Adjuncts Needed, Problems And Solutions: They Will Have A Role In All Vascular Beds Including BTK Arteries
  Presenter(s):Brian G. DeRubertis, MD / Krishna J. Rocha-Singh, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:34 AM - 9:39 AM Shockwave Intravascular Lithotripsy In Calcified Tibial Artery Lesions: How Well Does It Work
  Presenter(s):Andrew Holden, MBChB / Thomas Zeller, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:40 AM - 9:45 AM DCBs vs. DESs For SFA/Pop Lesions: Which Is Best And When With Midterm Follow-Up: From The DRASTICO Trial
  Presenter(s):Francesco Liistro, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:46 AM - 9:51 AM Combination Lesion Treatment With Passeo-18 Lux DCB And Pulsar-18 Uncoated Stent: Advantages And Good Results
  Presenter(s):Koen R. Deloose, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:52 AM - 9:58 AM When Is Distal Embolic Protection Needed During Lower Extremity Interventions: How Should It Be Performed
  Presenter(s):Peter A. Schneider, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
9:58 AM - 10:04 AM Panel Discussion
10:04 AM - 10:16 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 25
 
SESSION 26 SCHEDULE
Wednesday
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs), OTHER DEVICES FOR TREATMENT OF LOWER EXTREMITY OCCLUSIVE LESIONS, RANDOMIZED TRIALS (RCTs) AND BTK TREATMENTS
Location: Grand Ballroom East, 3rd Floor
Moderators:Michael S. Conte, MD / Antonio Micari, MD, PhD  
x
10:16 AM - 10:21 AM Impact And Significance Of Downstream Embolization And Restenosis With Different DCBs
  Presenter(s):Aloke Finn, MD / Renu Virmani, MD  
  View Slides in PDF      
10:22 AM - 10:27 AM DCBs Are Changing The Landscape And Algorithm For Treating Long Complex SFA/Pop Lesions And Minimizing The Need For Stents: Advantages Of Sirolimus vs. Paclitaxel Coatings
  Presenter(s):Thomas Zeller, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:28 AM - 10:33 AM Update On In.Pact SFA I And II RCTs Show Benefit Of In.Pact (Medtronic) DCBs Persisting And Increasing Over POBA At 4 years With Fem/Pop Lesions
  Presenter(s):John R. Laird, MD / Peter A. Schneider, MD / Gunnar Tepe, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:34 AM - 10:39 AM Update On Persistent Benefit Of Lutonix DCB (Bard/BD) For Fempop Lesions As Shown By A RCT vs. Plain Balloon Angioplasty (POBA): Long Lesions (>14 cm) Were Included
  Presenter(s):Kenneth Rosenfield, MD / Dierk Scheinert, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:40 AM - 10:45 AM COMPARE Pilot RCT: 1 Year Results Of A Randomized Comparison Of RANGER DCB vs. IN.PACT DCB In Complex SFA Lesions
  Presenter(s):Dierk Scheinert, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:46 AM - 10:51 AM Update On ILLUMINATE RCTs With Stellarex DCBs (Spectranetics/Philips): 2- And 3-Year Results For SFA/Pop Lesions And ISR Are Equal To Other DCBs: Advantages Over Other DCBs
  Presenter(s):Sean P. Lyden, MD / Timothy M. Sullivan, MD / Thomas Zeller, MD / Stefan Mueller-Huelsbeck, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:52 AM - 10:57 AM Lessons Learned From The In.Pact DCB GLOBAL Registry - Chronic Total Occlusion (CTO) Cohort: How To Make DCBs Work Best With CTOs
  Presenter(s):Marianne Brodmann, MD / Gunnar Tepe, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
10:58 AM - 11:03 AM In.Pact DCBs Have Equal Benefits When Treating Long SFA/Pop Lesions As When Treating Shorter Lesions
  Presenter(s):Antonio Micari, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:04 AM - 11:11 AM Panel Discussion
Moderator(s): Sean P. Lyden, MD / Giancarlo Biamino, MD, PhD  
11:11 AM - 11:16 AM What Is The Long-Term Durability Of The Benefits Of The Different DCBs: What Is The Value Of Spot Stenting Of Residual Stenoses With DCBs
  Presenter(s):Gunnar Tepe, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:17 AM - 11:22 AM Present Role For DCBs And DESs For SFA Lesions: Updated Treatment Algorithm And How To Deal With Severe Calcification
  Presenter(s):Fabrizio Fanelli, MD, EBIR  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:23 AM - 11:28 AM Update On Evaluation Of DCBs: When Are They Worthwhile And Advantages Of Different DCBs
  Presenter(s):Gary M. Ansel, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
DCBS FOR BTK LESIONS
11:29 AM - 11:34 AM Value Of DCBs In BTK And Crural Arteries: Reasons For Past Failures: New Technology, New Results And Promising Future Prospects
  Presenter(s):Francesco Liistro, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:35 AM - 11:40 AM Value Of Stellarex DCBs (Spectranetics/Philips) In BTK And Infrapopliteal Artery Lesions
  Presenter(s):Gunnar Tepe, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:41 AM - 11:46 AM > 1-Year Safety And Effectiveness Results Of Lutonix DCBs (Bard/BD) For Treating BTK And Crural Artery Lesions: Late Breaking Update And 6-Month Results Of Lutonix Below-The-Knee Global DCB IDE RCT Study
  Presenter(s):Patrick J. Geraghty, MD / Michael K.W. Lichtenberg, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:47 AM - 11:52 AM Update On Value Of The Chocolate Touch (Restrained) DCB (QT Vascular And TriReme Medical): What Makes It Different And 2-Year Results From The ENDURE Trial
  Presenter(s):Gunnar Tepe, MD / D. Christopher Metzger, MD  / Andrew Holden, MBChB / Wei Guo, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
11:53 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break - 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 26
 
SESSION 27 SCHEDULE
Wednesday
SESSION 27: EXOTIC AND EXTREME NEW TREATMENTS AND TECHNIQUES FOR SEVERE LOWER EXTREMITY OCCLUSIVE DISEASE AND CHRONIC LIMB THREATENING ISCHEMIA (CLTI): DEALING WITH THE “NO OPTION” FOR TREATMENT OR “UNSALVAGEABLE” LIMB AND THE “DESERT FOOT”
Location: Grand Ballroom East, 3rd Floor
Moderators:Daniel G. Clair, MD / Giancarlo Biamino, MD, PhD  
x
1:00 PM - 1:05 PM Is No Option CLTI Ever Real: Yes, But Rarely: How To Decrease The Major Amputation Rate: Open Bypasses Have A Role
  Presenter(s):Hisham Rashid, FRCS, FRCS(Gen)  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
1:06 PM - 1:11 PM Primary Open Bypass Is Better Than Endo-First Approach For CLTI Patients With Extensive Gangrene And Advanced WIfI Lesions
  Presenter(s):Francesco Spinelli, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
1:12 PM - 1:17 PM Latest Techniques And New Developments In Treating Leg And Foot Artery Lesions Causing CLTI With Extensive Ischemic Gangrene And Ulceration
  Presenter(s):Marco G. Manzi, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
1:18 PM - 1:23 PM Interventional Strategies For Treating So-Called No Option CLTI Patients: Such Patients Are Becoming Very Rare
  Presenter(s):Erwin Blessing, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
1:24 PM - 1:29 PM PQ (Percutaneous) Transvenous Arterial Fempop Bypass Procedure: Concept And Technique For Performing (Video)
  Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD / James D. Joye, DO  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
1:30 PM - 1:35 PM Percutaneous (PQ) Transvenous Fempop Arterial Bypass For Long (> 15 cm) SFA Occlusions: The DETOUR I And II Trial 2-Year Results: When Can It Work And When Can It Not
  Presenter(s):Sean P. Lyden, MD / 
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
ARTERIALIZATION OF FOOT VEINS
1:36 PM - 1:41 PM Open Surgical Arterial Bypasses To Deep Ankle Veins With Distal Vein Valve Disruption For CLTI With No Distal Target Arteries: Technique And Long-Term Results: It Works
  Presenter(s):Pramook Mutirangura, FRCS (Edinburgh)  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
1:42 PM - 1:47 PM Percutaneous Deep Vein Arterialization (pDVA) With The LimFlow Device For The No Option Patient With A “Desert” Foot: Technique, Results And Limitations
  Presenter(s):Steven Kum, MD / Daniel G. Clair, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
1:48 PM - 1:53 PM Pros And Cons Of Hybrid Deep Vein Arterialization Of Foot Veins For No Option CLTI Patients: It Can Work But . . .
  Presenter(s):Roberto Ferraresi, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
1:54 PM - 1:59 PM Hybrid Venous Arterialization: What Is It: How To Do It And When To Use It For No Option CLTI Patients
  Presenter(s):Miguel F. Montero-Baker, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
2:00 PM - 2:06 PM Panel Discussion
END OF SESSION 27
 
SESSION 28 SCHEDULE
Wednesday
SESSION 28: NEW DEVELOPMENTS IN LOWER EXTREMITY TREATMENTS WITH STENT-GRAFTS AND PROSTHETIC BYPASS GRAFTS; PROGRESS IN TREATING IN STENT RESTENOSIS (ISR)
Location: Grand Ballroom East, 3rd Floor
Moderators:Richard F. Neville, MD / Kenneth Ouriel, MD, MBA  
x
2:06 PM - 2:11 PM 8-Year Results Of Heparin Bonded PTFE Viabahn Stent Grafts For The Treatment Of Long TASC C And D Fempop Lesions: Advantages And Limitations
  Presenter(s):Maria Antonella Ruffino, MD, EBIR  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
2:12 PM - 2:17 PM DEBATE: PTFE Grafts With Bonded Heparin (Propaten) Have Patencies Approaching Those Of Saphenous Vein Grafts For Lower Extremity Bypasses: The Bonded Heparin Makes A Difference
  Presenter(s):Russell H. Samson, MD, RVT, FACS  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
2:18 PM - 2:23 PM DEBATE: Not So: The Heparin Bonding Is Not The Reason For The Good Results: Other Factors Are More Important
  Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
2:24 PM - 2:29 PM The SUPER B RCT Shows Viabahn Endografts Perform As Well As Open Surgical Fempop Bypass Grafts For 2 Years: Will DCBs To Prevent Edge Stenosis Improve The Viabahn Results
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
2:30 PM - 2:35 PM What Is The Best Current Treatment For ISR: DCBs Delay Re-Restenosis But There Is Catch-Up (From The COPA CABANA Trial): So What Is The Solution
  Presenter(s):Gunnar Tepe, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
2:36 PM - 2:41 PM Value Of Gore Viabahn Endografts To Treat ISR: Tips And Tricks For Successful Durable Use In This Setting
  Presenter(s):Marc Bosiers, MD / Koen R. Deloose, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
2:42 PM - 2:47 PM New Covered Balloon Expandable Stents: Which Ones Are Available (VBX-Gore; Lifestream-Bard/BD; BeGraft – Bentley): Advantages And Limitations Of Each: Tips For Use
  Presenter(s):Claudio J. Schonholz, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
2:48 PM - 2:53 PM Comparison Of 4 Balloon Expandable Covered Stents For Treatment Of Aorto- Iliac Occlusive Lesions: iCAST Or Advanta V12 Atrium (Maquet/Getinge); VBX (Gore); Lifestream (Bard/BD); BeGraft (Bentley); Which, Where And When
  Presenter(s):Andrew Holden, MBChB  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
2:54 PM - 3:00 PM Panel Discussion
3:00 PM - 3:10 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 28
 
SESSION 29 SCHEDULE
Wednesday
SESSION 29: LOWER EXTREMITY CLTI AND ITS TREATMENT: WHAT IS ITS BEST TREATMENT; RCTs; METHODS TO ASSESS FOOT PERFUSION AND TREATMENT SUCCESS; VALUE OF ANGIOSOME CONCEPT
Location: Grand Ballroom East, 3rd Floor
Moderators:Gary M. Ansel, MD / Joseph L. Mills, MD  
x
RCTS AND REGISTRIES OF CLTI TREATMENT
3:10 PM - 3:15 PM Update On The BEST-CLI RCT Comparing Open And Endo Treatments Of CLTI: Recruitment To Date: Successes And Problems To Date: What Will It Tell Us And When
  Presenter(s):Matthew T. Menard, MD / Alik Farber, MD / Kenneth Rosenfield, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
3:16 PM - 3:21 PM Status Of The BASIL 2 And 3 RCTs: 2 Compares Crural Vein Bypasses With Endo Treatments; 3 Compares DCBs/DESs With PTA And Uncoated Stents: What Will They Tell Us And When
  Presenter(s):Robert J. Hinchliffe, MD / Andrew W. Bradbury, MD, FRCSEd  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
3:22 PM - 3:27 PM These Trials Will Have Big Problems And May Tell Us Little About Their Primary End Points, But Will Provide Other Valuable Information
  Presenter(s):Mehdi H. Shishehbor, DO, MPH, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
3:28 PM - 3:33 PM New Findings From The SPINACH Study Of CLTI Treatments Show Bypass First Is Better With Extensive Gangrene And Infection: Otherwise Endo First Is Justified
  Presenter(s):Nobuyoshi Azuma, MD / Osamu Iida, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
3:34 PM - 3:39 PM Open Bypass Improves Perfusion More Than Endovascular Treatments: The Angiosome Concept Usually Does Not Matter: When Does It
  Presenter(s):Maarit Venermo, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
3:40 PM - 3:45 PM Duplex Ultrasound Is The Best Technique For Following BTK Interventions: Why It Improves Outcomes Big Time
  Presenter(s):Francesco Liistro, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
3:46 PM - 3:52 PM Panel Discussion
ASSESSING FOOT PERFUSION
3:52 PM - 3:57 PM Value Of Lumee Implantable Micro Oxygen Sensors In The Treatment Of CLTI Patients
  Presenter(s):Miguel F. Montero-Baker, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
3:58 PM - 4:03 PM Can Perfusion Angiography Judge Foot Perfusion And Predict Wound Healing In Patients With CLTI: From The REPEAT Trial
  Presenter(s):Jean-Paul de Vries, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
4:04 PM - 4:09 PM Perfusion Angiography (From Philips Health Care) To Assess The Functionality Of Sympathetic Activity And Foot Perfusion: It Is A Strong Predictor For Early Amputation In Ischemic Diabetic Foot Disease And A Way To Assess The Effects Of Revascularization Treatments
  Presenter(s):Jim Reekers, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
4:10 PM - 4:15 PM How To Measure Foot Perfusion After Tibial Interventions: These Measurements Are More Important Than Angiosomes
  Presenter(s):Werner Lang, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
4:16 PM - 4:21 PM Near Infrared Spectroscopy (NIRS) Is A Novel Non-Invasive Way To Measure Foot Perfusion When Other Methods Fail: How Does It Work And How Does It Help
  Presenter(s):Paolo Zamboni, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
4:22 PM - 4:27 PM DEBATE: Angiosome Directed Revascularization Improves Wound Healing With CLTI: When Does It Matter
  Presenter(s):Richard F. Neville, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
4:28 PM - 4:33 PM DEBATE: Why The Angiosome Concept Is Irrelevant In Most CLTI Patients With Tissue Necrosis
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
4:34 PM - 4:39 PM Pros And Cons About The Angiosome Concept: What Is Its Real Value And How Can It Improve Limb Salvage
  Presenter(s):Kenneth R. Ziegler, MD / Fred A. Weaver, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
4:40 PM - 4:45 PM Angiosomes Have Little Value In Diabetic Limb Salvage: WIfI Staging Is A Better Predictor Of Wound Healing Than “Direct” Revascularization
  Presenter(s):Christopher J. Abularrage, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
4:46 PM - 4:52 PM Panel Discussion
END OF SESSION 29
 
SESSION 30 SCHEDULE
Wednesday
SESSION 30: NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
Location: Grand Ballroom East, 3rd Floor
Moderators:Peter L. Faries, MD, FACS / John R. Laird, MD  
x
4:52 PM - 4:57 PM How To Get Patients To Recognize That Exercise And Neuromuscular Stimulation (NMES) Are Good Treatments For IC And To Comply With Them
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
INTERMITTENT CLAUDICATION
4:58 PM - 5:03 PM Update On Value And Logistics Of Exercise Treatment For Intermittent Claudication (IC): Things Are Getting Better And Why
  Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
5:04 PM - 5:09 PM A Recently Completed RCT Of Endovascular Revascularization vs. Supervised Exercise For IC: The SUPER Trial Results: Outcomes, QOL And Cost Effectiveness; How Does It Compare With The Other IC RCTs
  Presenter(s):Mark J.W. Koelemay, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
5:10 PM - 5:15 PM Exercise TcPO2 Can Distinguish Buttock IC From The Symptoms Of Spinal Stenosis: How Should Buttock IC Be Treated
  Presenter(s):Manju Kalra, MBBS  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
5:16 PM - 5:21 PM New And Current Data On All Cause And Cardiovascular Mortality In Patients With IC And CLTI: Have Recent Improvement In Medical Treatment And Statins Made A Difference
  Presenter(s):Gert J. de Borst, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
5:22 PM - 5:27 PM Differences In Decision Making For The Treatment Of IC In Europe And The US: Based On Data From The PORTRAIT Registry
  Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
5:28 PM - 5:33 PM Panel Discussion
ACUTE LIMB ISCHEMIA (ALI)
5:33 PM - 5:38 PM DEBATE: All ALI Patients Should Be Treated With An Endo First Policy And Over 90% Can Be Treated Entirely Endovascularly
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
5:39 PM - 5:44 PM DEBATE: Not So: Some Patients With ALI Should Have An Open Procedure First And Over 10% Will Require Some Open Component: Which Ones
  Presenter(s):Joseph L. Mills, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
5:45 PM - 5:50 PM More Effective Treatment Of ALI By Thrombolysis With Microbubbles And Ultrasound
  Presenter(s):Kak Khee Yeung, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
5:51 PM - 5:56 PM Current And New Data On Morbidity And Mortality Risks After Lower Extremity Embolectomy/Thrombectomy For ALI Open And Endo: Is It Less Than In The Past And Why
  Presenter(s):Alik Farber, MD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
5:57 PM - 6:02 PM Advances In The Endovascular Treatment Of ALI: Equipment, Techniques And Results
  Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD  
Location: Grand Ballroom East, 3rd Floor
  View Slides in PDF      
6:03 PM - 6:09 PM Panel Discussion
End of Program E
END OF SESSION 30
 
SESSION 31 SCHEDULE
Wednesday
SESSION 31: NEW DEVELOPMENTS AND ADVANCES IN MEDICAL AND ANTI-ATHEROGENIC TREATMENTS FOR PATIENTS WITH ARTERIAL DISEASE
Location: Grand Ballroom West, 3rd Floor
Moderators:Mehdi H. Shishehbor, DO, MPH, PhD / Geno J. Merli, MD, MACP, FHM, FSVM  
x
6:40 AM - 6:45 AM How Long Should Patients With DVT Be Kept On Anticoagulants: A Review Of The Data
  Presenter(s):Geoffrey Barnes, MD, MSc  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
6:46 AM - 6:51 AM What Are The New AHA Hypertension Guidelines And Why All PAD Patients Should Be Treated According To These Guidelines
  Presenter(s):Jeffrey W. Olin, DO  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
6:52 AM - 6:57 AM Benefits Of Cilostazol Before And After Peripheral Endovascular Procedures: What Regimen And Dosage Should Be Given Routinely
  Presenter(s):Gary M. Ansel, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
6:58 AM - 7:03 AM What Is Anacetrapib: Do CETP Inhibitors To Reduce LDL Cholesterol (LDL-C) More Than Statins Have A Role In PAD Patients: What About Ezetemibe (Zetia): How Low An LDL-C Should We Try To Get
  Presenter(s):Kavita Sharma, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
7:04 AM - 7:09 AM PCSK-9 Inhibitors: Highlights For The Vascular Specialist In 2018
  Presenter(s):Pradeep Natarajan, MD, MMSc  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
7:10 AM - 7:15 AM DEBATE: Statins Are Dangerous Drugs: Lowering LDL-C Does No Good And Is Harmful In Most Patients
  Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
7:16 AM - 7:21 AM DEBATE: Not So: Lowering LDL-C Levels With Statins And PCSK-9 Inhibitors In At Risk Patients With PAD Prevents Cardiovascular Events And Deaths; It Is Safe And Prolongs Life
  Presenter(s):Ron Waksman, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
7:22 AM - 7:27 AM How Important Is It To Give High Intensity Statins To PAD Patients: How Low Should We Push Their LDL-C, To <50 mg/dL; What About Adding Other Drugs: What About Statins In Older (>80) PAD Patients
  Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC  / Caron B. Rockman, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
7:28 AM - 7:33 AM DEBATE: What Did The COMPASS RCT Show: After This Trial, Rivaroxaban Plus Aspirin Should Be Given To All PAD Patients To Lower Their Risk Of Stroke, MI And Death: What Doses
  Presenter(s):Jay Giri, MD, MPH  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
7:34 AM - 7:39 AM DEBATE: Not So Fast: We Still Need To Know More Before Adding Rivaroxaban For PAD Patients
  Presenter(s):Brian H. Annex, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
7:40 AM - 7:46 AM Panel Discussion
END OF SESSION 31
 
SESSION 32 SCHEDULE
Wednesday
SESSION 32: MORE ON MEDICAL TREATMENTS AND NEW TECHNIQUES FOR TREATING RESISTANT HYPERTENSION; PREDICTIONS FOR THE FUTURE
Location: Grand Ballroom West, 3rd Floor
Moderators:David H. Deaton, MD, FACS / Ido Weinberg, MD, MSc  
x
7:46 AM - 7:51 AM Can Renal Denervation Still Be An Effective Treatment For Resistant Hypertension: Results With The Spyral-HTN Device (Medtronic) In A Sham Controlled RCT Suggest It Can: What About Other Endovascular Treatments
  Presenter(s):Horst Sievert, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
7:52 AM - 7:57 AM The Mobius HD Intra-Arterial Implant (From Vascular Dynamics) To Stimulate Baroreceptor Activity And Lower BP (The CALM-2 Trial): How Does It Work And Results To Date
  Presenter(s):Kim J. Hodgson, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
7:58 AM - 8:03 AM The ROX Coupler To Create An Iliac A-V Fistula And Control Resistant Hypertension: Positive Results Of The CONTROL HTN-2 Sham Controlled RCT: Will Blood Pressure Measurement With Light-Sensitive Finger Photoplethysmography Become A Reality
  Presenter(s):David H. Deaton, MD, FACS / Krishna J. Rocha-Singh, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
8:04 AM - 8:09 AM DEBATE: Beta Blockers Lower The Postoperative Mortality Of Patients Undergoing Open Repair Of AAAs: What Drug Dose And Timing Should Be Used
  Presenter(s):Mahmoud B. Malas, MD, MHS  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
8:10 AM - 8:15 AM DEBATE: The Evidence Supporting The Value Of Peri-Operative Beta Blockers In Lowering Morbidity Of Vascular Procedures Is Weak And They May Be Harmful: What Should We Do: Is It Just A Dosage Problem
  Presenter(s):Peter Henke, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
8:16 AM - 8:21 AM What Is The Optimal Medical Treatment For Patients With CLTI; With PAD: How Much Will Medical Treatment Replace Invasive Interventions By 2028
  Presenter(s):Ido Weinberg, MD, MSc / Michael R. Jaff, DO  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
8:22 AM - 8:28 AM Panel Discussion
8:28 AM - 8:33 AM Adherence To Lipid Guidelines (Which Ones) In CLTI Patients Undergoing Open And Endo Revascularization Leads To A Decrease In Mortality And Major Adverse Limb Events (MALEs): How Low Should The LDL-C Be Pushed
  Presenter(s):Marc L. Schermerhorn, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
8:34 AM - 8:39 AM Implications Of The CANTOS Trial Showing That An Anti-Inflammatory Drug (Canakinumab From Novartis) Reduces Strokes, MIs And Deaths Without Changing LDL-C Levels
  Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC  / Caron B. Rockman, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
8:40 AM - 8:45 AM PCSK-9 Inhibitor (Evolocumab) Plus Statins Decreases MI, Stroke, MALE And Death More In PAD And Recent MI Patients Than Others: From A FOURIER RCT Trial Subanalysis: What LDL-C Level Should We Aim For
  Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC   
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
8:46 AM - 8:51 AM The Best Antiplatelet And Anticoagulant Medications For Patients With Aggressive PAD: How Important Are LDL-C Levels: When Should Ezetemibe (Zetia) And PCSK-9 Inhibitors Be Added To Statins
  Presenter(s):Peter Henke, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
8:52 AM - 8:57 AM Is There A Future For Bioresorbable Stents In The Coronary Arteries Or Elsewhere
  Presenter(s):Ron Waksman, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
8:58 AM - 9:04 AM Panel Discussion
END OF SESSION 32
 
SESSION 33 SCHEDULE
Wednesday
SESSION 33: PROGRESS IN THE MANAGEMENT OF COMPLICATIONS AND ENDOLEAKS
Location: Grand Ballroom West, 3rd Floor
Moderators:Michel Makaroun, MD / Frans L. Moll, MD, PhD  
x
9:04 AM - 9:09 AM Retroperitoneal Hemorrhage Is Life-Threatening: Vascular Specialists Should Never Cause It: How To Prevent It: How To Diagnose And Treat It
  Presenter(s):Russell H. Samson, MD, RVT, FACS  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
9:10 AM - 9:15 AM Lower Extremity Ischemic Complications With EVAR And F/EVAR: Causes And Treatment
  Presenter(s):Thomas S. Maldonado, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
ENDOLEAKS AFTER EVAR
9:16 AM - 9:21 AM Management Strategies For Type 1a Endoleaks After EVAR: When Can They Be Ignored And When Must They Be Treated: What Treatment Is Best And When
  Presenter(s):Murray L. Shames, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
9:22 AM - 9:27 AM When Can Embolization Techniques Fix Type 1 Endoleaks After EVAR: Which Agents Are Best And Technical Tips
  Presenter(s):Robert A. Morgan, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
9:28 AM - 9:33 AM DEBATE: Type 2 Endoleaks With Increasing AAA Sac Size Are Dangerous And Usually Must Be Treated: Here Is The Evidence
  Presenter(s):Jean-Pierre Becquemin, MD, FRCS  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
9:34 AM - 9:39 AM DEBATE: There Is No Evidence That Treating Type 2 Endoleaks Is Beneficial And Such Treatment May Be Harmful
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
9:40 AM - 9:45 AM Transcaval Embolization Of Type 2 Endoleaks After EVAR: Indications, Technique, Precautions And Results
  Presenter(s):Clifford M. Sales, MD, MBA, FACS  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
9:46 AM - 9:51 AM Contrast Enhanced Ultrasound (CEUS) To Facilitate Effective Treatment Of Type 2 Endoleaks
  Presenter(s):Thanila A. Macedo, MD / Gustavo S. Oderich, MD, FACS  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
9:52 AM - 9:57 AM When And How To Treat Type 2 Endoleaks: How Often Is Treatment Effective; How Often Is It Not
  Presenter(s):Marc L. Schermerhorn, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
9:58 AM - 10:03 AM Onyx To Treat Type 2 Endoleaks: Technique And Precautions To Do It Safely And Effectively And Be Sure It Gets Into The Nidus
  Presenter(s):Mark W. Mewissen, MD, RVT  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
10:04 AM - 10:12 AM Panel Discussion
10:12 AM - 10:28 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 33
 
SESSION 34 SCHEDULE
Wednesday
SESSION 34: TRIBUTES TO VASCULAR GREATS; ISSUES RELATED TO A VASCULAR PRACTICE – PROBLEMS TO BE FACED AND HOW TO DEAL WITH THEM AND SUCCEED: ARTIFICIAL INTELLIGENCE AND HISTORY
Location: Grand Ballroom West, 3rd Floor
Moderators:R. Clement Darling III, MD / Kim J. Hodgson, MD  
x
A BIT OF HISTORY
10:28 AM - 10:33 AM My Diversion To Gander, Newfoundland On 9/11/2001 And What It Taught Me: The Play “Come From Away” Brought Back Memories
  Presenter(s):Klaus D. Mathias, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
TRIBUTES TO GIANTS
10:34 AM - 10:39 AM A Tribute To Frank A. Lederle, MD (1952-2018)
  Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
10:40 AM - 10:45 AM A Tribute To Anthony (Tony) M. Imparato (1922-2018)
  Presenter(s):Mark A. Adelman, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
ISSUES FOR VASCULAR SURGEONS
10:46 AM - 10:51 AM Is The Double Booked Vascular Surgeon A Thing Of The Past: Not Totally: What Are The Limitations
  Presenter(s):Vincent J. Santo III, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
10:52 AM - 10:57 AM White Coat Crime In Vascular Surgery: What Is It And How Can It Be Stopped
  Presenter(s):Russell H. Samson, MD, RVT, FACS  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
10:58 AM - 11:03 AM Physical Ailments That Accrue To Vascular Surgeons From Their Work: What Are The Causes: How To Measure And Prevent Them
  Presenter(s):Samuel R. Money, MD, MBA  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
11:04 AM - 11:11 AM Panel Discussion
11:11 AM - 11:16 AM Life After Being A Busy Successful Surgeon: When And How To Stop Operating And Still Have A Useful Enjoyable Life
  Presenter(s):Simran B. Singh, MD, MBA  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
11:17 AM - 11:22 AM How Can Vascular Surgeon-Scientists Survive In Today’s Unfriendly DRG/RVU Climate
  Presenter(s):Peter Henke, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
11:23 AM - 11:28 AM Key Personal Qualities That Help One To Achieve Success In Vascular Surgery And Other Vascular Specialties
  Presenter(s):Tej M. Singh, MD, MBA  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
11:29 AM - 11:34 AM Challenges And Keys To Success For Women In Vascular Surgery
  Presenter(s):Rebeca Reachi Lugo, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
11:35 AM - 11:40 AM What Measures Need To Be Taken To Promote The Well-Being Of Vascular Surgeons In Today’s Medical Climate
  Presenter(s):Cynthia K. Shortell, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
ARTIFICIAL INTELLIGENCE IN MEDICINE
11:41 AM - 11:46 AM Role Of Artificial Intelligence And Big Data In Health Care: Are Doctors’ Jobs In Danger
  Presenter(s):Ido Weinberg, MD, MSc  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
11:47 AM - 11:52 AM How Innovation Is Changing Health Care: Artificial Intelligence, Amazon, Google, Etc. Will Revolutionize Things In the Future
  Presenter(s):Eugene M. Langan III, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
11:53 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break - 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 34
 
SESSION 35 SCHEDULE
Wednesday
SESSION 35: ISSUES RELATED TO OUTPATIENT CENTERS, PODIATRY, REIMBURSEMENTS, PERFORMANCE AND COST CONTROL
Location: Grand Ballroom West, 3rd Floor
Moderators:Enrico Ascher, MD / Manish Mehta, MD, MPH  
x
1:00 PM - 1:05 PM Office Or Outpatient Centers Are The Best Place To Perform Most Arterial And Venous Interventional Treatments: Precautions And Current Status Of Their Accreditation And Reimbursement
  Presenter(s):Krishna Jain, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
1:06 PM - 1:11 PM What Is The OEIS (Outpatient Endovascular And Interventional Society); How Can It Help Vascular Surgeons And Specialists And Their Patients
  Presenter(s):Jeff G. Carr, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
1:12 PM - 1:17 PM DEBATE: Outpatient Atherectomy For IC (Claudication) Leads To Worse Outcomes And More Amputations Than The Natural History Of The Disease: From Medicare Billing Data
  Presenter(s):Dipankar Mukherjee, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
1:18 PM - 1:23 PM DEBATE: Not So: Why Outpatient Atherectomy Should Not Increase Amputation Rates But Should Decrease Them: Why The Medicare Data Is Misleading
  Presenter(s):Lawrence A. Garcia, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
1:24 PM - 1:29 PM New Concepts In Podiatry Important To Vascular Surgeons/Specialists: Game Changing Single Dose Antibiotic (Dalbavancin) For Foot Infections And How To Avoid Opiods For Pain
  Presenter(s):Wayne J. Caputo, DPM  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
1:30 PM - 1:35 PM Panel Discussion
REIMBURSEMENT AND COST ISSUES
1:35 PM - 1:40 PM What Is Happening With MACRA And The Other Alphabet Soup Entities Impacting On Reimbursement
  Presenter(s):Timothy F. Kresowik, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
1:41 PM - 1:46 PM Why Endovascular Treatments For CLTI Are More Cost Effective Than Open Surgery Or Amputation In The Drug Eluting Era
  Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
1:47 PM - 1:52 PM Strategies For Decreasing Costs Without Decreasing Success In A PVD Practice
  Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
1:53 PM - 1:58 PM What Are The Latest Objective SFA-Pop Performance Goals: How Do They Influence Patient Care And Costs
  Presenter(s):Jack L. Cronenwett, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
1:59 PM - 2:04 PM V-HEALTHY: A Program To Increase Vascular Disease Awareness And The Role And Importance Of Vascular Surgeons: How Does It Work
  Presenter(s):Manish Mehta, MD, MPH  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
2:05 PM - 2:11 PM Innovation In Vascular Surgery: What Does It Take To Develop A New Treatment And Change The Standard Of Care
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
2:11 PM - 2:16 PM Panel Discussion
END OF SESSION 35
 
SESSION 36 SCHEDULE
Wednesday
SESSION 36: MORE ISSUES RELATED TO QUALIFICATIONS, GOVERNMENT, COMPENSATION OR INCOMES, INCENTIVES, PUBLIC REPORTING OF OUTCOMES, PROCEDURAL USAGE AND VALUE OF VASCULAR SURGEONS
Location: Grand Ballroom West, 3rd Floor
Moderators:Keith D. Calligaro, MD / Bruce A. Perler, MD, MBA  
x
2:16 PM - 2:21 PM Why European Qualifications In Vascular Surgery Will Have Increasing Importance: How Will It Help Vascular Surgeons And Patients
  Presenter(s):Armando Mansilha, MD, PhD, FEBVS  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
2:22 PM - 2:27 PM What Is Happening With Vascular Device Evaluation And Approval At The FDA: How Is It Helping Vascular Surgeons Develop And Get To Use New Devices
  Presenter(s):Dorothy B. Abel, BSBME  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
2:28 PM - 2:33 PM How Is The SVS Coding And Government Relations Committees And The SVS PAC Helping Vascular Surgeons’ Incomes
  Presenter(s):Sean P. Roddy, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
2:34 PM - 2:39 PM How To Design A Fair Compensation Package For Academic Vascular Surgeons: It Should Not Just Be About RVUs And DRGs
  Presenter(s):Mark G. Davies, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
2:40 PM - 2:45 PM Pay For Performance (P4P) Incentive Systems Are Flawed: What Frustrations Do They Cause For Vascular Surgeons/Specialists Dealing With High Risk Patients And How Can These Be Overcome
  Presenter(s):James W. Jones, MD, PhD, MHA  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
2:46 PM - 2:52 PM Panel Discussion
2:52 PM - 2:57 PM DEBATE: Public Reporting Of Individual Vascular Surgeons And Other Vascular Specialists Is A Good Thing For Patients
  Presenter(s):Bruce A. Perler, MD, MBA  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
2:58 PM - 3:03 PM DEBATE: No: Such Reporting Is Bad For Patients, Society And Specialists: Here Is Why
  Presenter(s):Ian Loftus, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
3:04 PM - 3:09 PM Factors Influencing Usage Of Procedures (Like Carotid Revascularizations) By Doctors: Maintenance Of Incomes Is A Major Factor And Could Be Detrimental To Patients
  Presenter(s):Philip P. Goodney, MD, MS  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
3:10 PM - 3:15 PM Why Do Some Alleged Vascular Surgeons Perform 1 Or 2 AAA Repairs Per Year: What Is The Result And How Can The Problem Be Fixed
  Presenter(s):Jack L. Cronenwett, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
3:16 PM - 3:21 PM Urgent Operative Consultations Provided By Vascular Surgeons - Usually To Stop Bleeding: Skills We Have That Others Need: Can Our Value Be Compensated And Is It
  Presenter(s):Michael Belkin, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
3:22 PM - 3:27 PM Panel Discussion
3:27 PM - 3:36 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 36
 
SESSION 37 SCHEDULE
Wednesday
SESSION 37: ISSUES RELATED TO MALPRACTICE, VASCULAR CARE AND THE VALUE AND WELL-BEING OF VASCULAR SURGEONS
Location: Grand Ballroom West, 3rd Floor
Moderators:Michel Makaroun, MD / R. Clement Darling III, MD  
x
3:36 PM - 3:41 PM How To Neutralize And Unmask Hostile Medical Expert Witnesses And Their Testimony
  Presenter(s):O. William Brown, MD, JD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
3:42 PM - 3:47 PM Why Is The EPIC EHR System Currently Such A Problem For Vascular Surgeons/Specialists: Can It Be Improved: Are There Better Systems
  Presenter(s):Timothy F. Kresowik, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
3:48 PM - 3:53 PM How To Decrease The Cost Of Vascular Care Delivery For Lower Extremity And EVAR Procedures Without Impairing Quality
  Presenter(s):Richard J. Powell, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
3:54 PM - 3:59 PM How To Let Vascular Patients Share More In Their Treatment Decisions: What Tools Are Available: The OVIDIUS Trial
  Presenter(s):Dirk T. Ubbink, MD, PhD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
4:00 PM - 4:05 PM EVAR And Carotid Interventions Can Have Durable Good Results In Patients Over 80: How Can Results Be Improved In Elderly Patients
  Presenter(s):B. Patrice Mwipatayi, MMed, MClinEd  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
4:06 PM - 4:11 PM Eliminating Avoidable Disasters In The OR And Managing Them When They Occur
  Presenter(s):Robert B. McLafferty, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
4:12 PM - 4:17 PM Panel Discussion
4:17 PM - 4:22 PM Why We Need To Centralize Vascular Care For AAAs And CLTI: Will It Happen
  Presenter(s):Michael C. Stoner, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
4:23 PM - 4:28 PM How A Certification Plan For Vascular Centers Will Be Structured: Will It Happen And How Will It Help Vascular Surgery
  Presenter(s):Anton N. Sidawy, MD, MPH  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
4:29 PM - 4:34 PM Recognition Of Burnout In Vascular Surgeons: Strategies To Prevent And Overcome It
  Presenter(s):John (Jeb) W. Hallett, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
4:35 PM - 4:40 PM How To Optimize And Reward The Value Of A Vascular Surgeon In A Large Health Care System
  Presenter(s):Ronald M. Fairman, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
4:41 PM - 4:46 PM Panel Discussion
END OF SESSION 37
 
SESSION 38 SCHEDULE
Wednesday
SESSION 38: ISSUES RELATED TO THE SVS, VQIs, GUIDELINES, TRIALS, ETHICS AND THE JVS
Location: Grand Ballroom West, 3rd Floor
Moderators:Kenneth Ouriel, MD, MBA / Anton N. Sidawy, MD, MPH  
x
4:46 PM - 4:51 PM Current Status, Advantages And Limitations Of The SVS VQI
  Presenter(s):Larry W. Kraiss, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
4:52 PM - 4:57 PM How VQIs Can Be Used To Help Set Ethical Standards
  Presenter(s):Thomas W. Wakefield, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
4:58 PM - 5:03 PM How VQIs Can Help To Develop Good RCTs
  Presenter(s):Mohammad H. Eslami, MD, MPH  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
5:04 PM - 5:09 PM Highlights And Key Messages From The New SVS Practice Guidelines For Care Of AAA Patients
  Presenter(s):Elliot L. Chaikof, MD, PhD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
5:10 PM - 5:15 PM Highlights And Key Messages From The UK Guidance Document On AAA Treatment
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
5:16 PM - 5:21 PM SVS Guidelines For Hospital Privileges For Vascular Surgeons In The US
  Presenter(s):Keith D. Calligaro, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
5:22 PM - 5:27 PM Panel Discussion
5:27 PM - 5:32 PM Why Registries Can Be Better Than RCTs For Evaluating Vascular Devices
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
5:33 PM - 5:38 PM Traditional Clinical Trials In Vascular Disease Have Problems: How Can We Fix This With Bayesian Trial Designs
  Presenter(s):Charles C. Miller, PhD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
5:39 PM - 5:44 PM Why Do So Many Trials Of Treatments For CLTI Fail: What Is The Best Design To Prevent Failure In This Setting
  Presenter(s):Mahmood Razavi, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
5:45 PM - 5:50 PM Update On Status Of And Improvements In The JVS: How To Review A Paper For The JVS
  Presenter(s):Peter F. Lawrence, MD / Peter Gloviczki, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
5:51 PM - 5:56 PM How To Make A Paper Have The Best Chance Of Getting Published In The JVS Despite A High Rejection Rate
  Presenter(s):Peter Gloviczki, MD / Peter F. Lawrence, MD  
Location: Grand Ballroom West, 3rd Floor
  View Slides in PDF      
5:57 PM - 6:03 PM Panel Discussion
End of Program F
END OF SESSION 38
 
SESSION 39 SCHEDULE
Wednesday
SESSION 39: MORE TOPICS RELATED TO THE THORACIC AORTA, TEVAR, AORTIC DISSECTIONS AND THEIR TREATMENT
Location: Trianon Ballroom, 3rd Floor
Moderators:ShenMing Wang, MD, PhD / William D. Jordan Jr., MD  
x
6:45 AM - 6:50 AM Why Left Subclavian Artery (LSA) Revascularization With TEVAR Is Best Accomplished With A Carotid-To-Axillary Bypass Rather Than By A Carotid-To-LSA Bypass Or Transposition: Technical Tips
  Presenter(s):Frank J. Criado, MD, FACS, FSVM  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
6:51 AM - 6:56 AM System For Preoperative Risk Assessment For TEVAR Outcomes
  Presenter(s):Richard G.J. Gibbs, FRCS  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
6:57 AM - 7:02 AM How Best To Size (Diameter) Endografts For TEVAR: For Treatment Of Aneurysms, TBADs And Traumatic Aortic Injuries
  Presenter(s):Thomas S. Maldonado, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
7:03 AM - 7:08 AM At What Size (Diameter) Should Asymptomatic Thoracic Aortic Aneurysms (TAAs) Undergo Treatment By TEVAR
  Presenter(s):Robert J. Hinchliffe, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
7:09 AM - 7:14 AM Impact Of TEVAR On Pulsatile Aortic Strain In Acute TBAD: What Is Its Clinical Significance
  Presenter(s):Frans L. Moll, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
7:15 AM - 7:20 AM Panel Discussion
TBAD RELATED TOPICS
7:20 AM - 7:25 AM 4-Year Outcomes Of TBAD Treatment With The Valiant Device (From Medtronic) For TEVAR
  Presenter(s):Ali Azizzadeh, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
7:26 AM - 7:31 AM Invasive Treatment In Patients With Genetically Triggered Aortopathy (Like Marfan’s): When Is Endovascular Treatment Acceptable And When Not
  Presenter(s):Cherrie Z. Abraham, MD  
  View Slides in PDF      
7:32 AM - 7:37 AM Risk Factors For New Distal Endovascular Graft Induced Re-Entry Tears After TEVAR For TBADs: How To Avoid Them
  Presenter(s):Ludovic Canaud, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
7:38 AM - 7:43 AM Importance Of The Primary Tear Distance From The LSA In Predicting Aortic Growth With TBADs
  Presenter(s):William D. Jordan Jr., MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
7:44 AM - 7:49 AM When And How To Intervene For Endoleaks And False Lumen Perfusion After TEVAR For TBADs
  Presenter(s):Manish Mehta, MD, MPH  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
7:50 AM - 7:55 AM How Can False Lumen Intentional Placement (FLIP) Of An Endograft Facilitate Repair Of A Chronic TBAD With TAAA Formation: Techniques And Results
  Presenter(s):William J. Quinones-Baldrich, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
7:56 AM - 8:01 AM Panel Discussion
END OF SESSION 39
 
SESSION 40 SCHEDULE
Wednesday
SESSION 40: MORE NEW DEVELOPMENTS IN THE TREATMENT OF LESIONS OF THE ASCENDING AORTA AND THE AORTIC ARCH
Location: Trianon Ballroom, 3rd Floor
Moderators:Mark A. Adelman, MD / Frank R. Arko, MD  
x
8:01 AM - 8:06 AM Risk Factors For Retrograde Type A Dissections After TEVAR Procedures And How To Avoid Them And Treat Them
  Presenter(s):Frank R. Arko, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
8:07 AM - 8:12 AM Ascending Aortic Aneurysms Are Over-Diagnosed Using Cardiology Guidelines: When Is The Ascending Aorta Really Aneurysmal
  Presenter(s):Jes S. Lindholt, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
8:13 AM - 8:18 AM Early Multicenter Experience With The Gore Ascending Aortic Off-The-Shelf (OTS) Endograft: Indications, Contraindications, Advantages And Results
  Presenter(s):Jean Bismuth, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
8:19 AM - 8:24 AM Technical Tips For Open Arch Replacement In Type A Aortic Dissections (TAADs) To Facilitate Subsequent TAAA Repair
  Presenter(s):Christian D. Etz, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
8:25 AM - 8:30 AM Chimney TEVAR (Ch/TEVAR) To Treat Aortic Arch Lesions: Long-Term Good Outcomes And How To Achieve Them
  Presenter(s):Martin R. Back, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
8:31 AM - 8:36 AM How To Prevent Gutter Endoleaks With Arch Chimney Grafts (Ch/TEVAR)
  Presenter(s):Jan S. Brunkwall, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
8:37 AM - 8:43 AM Panel Discussion
8:43 AM - 8:48 AM New Concepts For Better Understanding Aortic Arch Pathology, Its Progression And Treatment
  Presenter(s):Santi Trimarchi, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
8:49 AM - 8:54 AM Retrograde Type A Aortic Dissections After TEVAR: Etiologic Factors Can Be Operator Dependent; Device Dependent And/Or Disease Dependent: How To Prevent And Treat Them
  Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
8:55 AM - 9:00 AM Open vs. Endo Arch Reconstructions In 2018: What Is Evidence-Based And What Is Anecdote-Based
  Presenter(s):Christoph A. Nienaber, MD, PhD / Nicholas J.W. Cheshire, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
9:01 AM - 9:06 AM Update On The Gore Retrograde Single Branched Endograft Device For Treating Aortic Arch Lesions: Advantages, Precautions And Results
  Presenter(s):Michael D. Dake, MD / Michel Makaroun, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
9:07 AM - 9:12 AM Percutaneous Transapical Approach For Placing Arch And Other Devices: How Is It Possible
  Presenter(s):Ross Milner, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
9:13 AM - 9:18 AM How To Manage A Chronically Diseased Aorta Distal To A Previous Surgical Or Endograft Treated TAAD
  Presenter(s):Jean-Marc Alsac, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
9:19 AM - 9:25 AM Panel Discussion
9:25 AM - 9:40 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 40
 
SESSION 41 SCHEDULE
Wednesday
SESSION 41: MORE ABOUT JUXTA- AND PARARENAL AAAs, F/B/EVAR, TAAAs, NEW ENDOGRAFTS, SANDWICH GRAFTS AND HYBRID GRAFTS
Location: Trianon Ballroom, 3rd Floor
Moderators:Mark A. Adelman, MD / Mark A. Farber, MD  
x
9:40 AM - 9:45 AM New Advances In Open TAAA Repair Especially After Endovascular Treatment Failures: Technical Tips And Results
  Presenter(s):Roberto Chiesa, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
9:46 AM - 9:51 AM DEBATE: Endovascular Repair Is The Best Treatment For Most TAAAs – Especially With The Availability Of Some Newer Endograft Systems
  Presenter(s):Mark A. Farber, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
9:52 AM - 9:57 AM DEBATE: Not So: Many TAAAs Are Best Treated By Open Surgery: Technical Pearls To Improve Results
  Presenter(s):Virendra I. Patel, MD, MPH  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
9:58 AM - 10:03 AM Why Open Surgery Is Still The Best Treatment For Juxta- And Pararenal AAAs In Good Risk Patients: Technical Tips
  Presenter(s):Kimihiro Komori, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
10:04 AM - 10:09 AM Update On The Sandwich Technique For Treating Complex TAAAs: Technical Tips, Precautions And Results
  Presenter(s):Armando C. Lobato, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
10:10 AM - 10:15 AM Endovascular Options For Treating TAAAs: What Off-Label Options Are Safe And Effective
  Presenter(s):Murray L. Shames, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
10:16 AM - 10:21 AM Propensity Matched Comparison Of F/B/EVAR And Open Repair For TAAAs Shows That Endovascular Treatment Is Best
  Presenter(s):Piergiorgio Cao, MD, FRCS  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
10:22 AM - 10:27 AM Tips And Tricks For Performing B/EVAR Without Axillary Access
  Presenter(s):Stephan Haulon, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
10:28 AM - 10:34 AM Panel Discussion
Moderator(s): Stephan Haulon, MD / Ali F. AbuRahma, MD  
10:34 AM - 10:39 AM Visceral Manifold Endograft System From Medtronic For Treating Complex AAAs And TAAAs: Advantages, Precautions And Midterm Results: When Will It Be Available Commercially
  Presenter(s):Patrick W. Kelly, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
10:40 AM - 10:45 AM Update On A New Manifold Multibranched Endo Device (Colt Device) For Improving TAAA Treatment: Concept, Advantages And Results
  Presenter(s):Piotr Szopinski, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
10:46 AM - 10:51 AM Update On The Spider Hybrid Graft For Partially Open TAAA Repair Without A Thoracotomy: How It Works, Clinical Experience, Advantages And Limitations
  Presenter(s):Sebastian E. Debus, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
10:52 AM - 10:57 AM Open Repair For Visceral Segment TAAAs After TEVAR: The Reverse Cactus Operation: A Good Option When Endo Treatment Is Not Possible: Technique And 1-Year Results
  Presenter(s):Francesco Spinelli, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
10:58 AM - 11:03 AM Chimney EVAS (Ch/EVAS) With The Nellix Device For Juxta- And Pararenal AAAs: Tips And Tricks For Performing And Results Of The ASCEND Trials 1 And 2 (IDE)
  Presenter(s):Ian Loftus, MD / Pete Holt, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
11:04 AM - 11:09 AM Branched EVAR (B/EVAR) Through The False Lumen For Chronic TBADs With TAAAs: Why Is It Necessary: How To Do It And Results
  Presenter(s):Piotr M. Kasprzak, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
11:10 AM - 11:15 AM Adjuncts To Achieve Better Sealing And AAA Exclusion With F/EVAR And Ch/EVAR: Value Of Viabahn BX (Balloon Expandable) Branch Grafts As Shown In An In Vitro Model
  Presenter(s):Jan D. Blankensteijn, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
11:16 AM - 11:22 AM Panel Discussion
END OF SESSION 41
 
SESSION 42 SCHEDULE
Wednesday
SESSION 42: UPDATE ON MULTILAYER FLOW MODULATING BARE STENTS FOR THE TREATMENT OF PERIPHERAL AND VISCERAL ANEURYSMS, COMPLEX AORTIC ANEURYSMS AND DISSECTIONS
Location: Trianon Ballroom, 3rd Floor
Moderators:Rodney A. White, MD / Wayne W. Zhang, MD  
x
11:22 AM - 11:27 AM Why Multilayer Flow Modulating Bare Stents (From Cardiatis) Are The Treatment Of Choice For Peripheral And Visceral Aneurysms: What Is The Evidence: These Are The Results
  Presenter(s):Michel Henry, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
11:28 AM - 11:33 AM Update On The Value Of Treating Aortic Aneurysms And Dissections With A Combination Of Multilayered Uncovered Stents Together With Covered Stents: Indications, Techniques And Results
  Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
11:34 AM - 11:39 AM When Is The Multilayered Flow Modulating Bare Stent A Good Treatment For TBADs And The Treatment Of Choice For Penetrating Aortic Ulcers (PAUs): Indications, Precautions And Results
  Presenter(s):Ralf R. Kolvenbach, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
11:40 AM - 11:45 AM Multilayer Flow Modulating Bare Stents: Long-Term Results In Aortic Dissections And Complex AAAs And TAAAs: When Do They Work And When Don’t They: From The DRAGON Multicenter Trial
  Presenter(s):Claude D. Vaislic, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
11:46 AM - 11:51 AM Value Of Multilayer Flow Modulating Stents In Treating Complex Aortic Pathology: They Are Effective In Aortic Dissections: What About With Complex AAAs
  Presenter(s):Ivo Petrov, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
11:52 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – 2nd Floor Promenade
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 42
 
SESSION 43 SCHEDULE
Wednesday
SESSION 43: MORE INTERESTING TOPICS RELATED TO INFRARENAL AAAs AND STANDARD EVAR AND TBADs
Location: Trianon Ballroom, 3rd Floor
Moderators:Frans L. Moll, MD, PhD / Juan C. Parodi, MD  
x
1:00 PM - 1:05 PM Off-Label Use Of EVAR Devices For Treating AAAs With Challenging Neck Anatomy Is Safe And Effective Under Certain Conditions: What Are They
  Presenter(s):Martin Malina, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
1:06 PM - 1:11 PM Should Mesh Reinforcement Of Abdominal Incisions Be The Standard Of Care For Open AAA Surgery To Prevent Wound Complications: Based On RCTs
  Presenter(s):Mark J.W. Koelemay, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
1:12 PM - 1:17 PM Multilayer Flow Modulating (MFM) Stents Are A Safe And Effective Option For Treating Complex Type B Aortic Dissections (TBADs): Based On A 4-Year Experience
  Presenter(s):Victor S. Costache, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
1:18 PM - 1:23 PM EVAR 2’s Level 1 Evidence No Longer Applies For Many Reasons: Why EVAR Is Currently Indicated In Many Patients Unfit For Open Repair: Which Ones
  Presenter(s):Frank E.G. Vermassen, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
1:24 PM - 1:29 PM Of Course EVAR Is Indicated In Many Patients Who Could Not Undergo An Open Repair: This Is An Example Of RCT Level 1 Evidence Being Outdated And No Longer Applicable To Current Practice
  Presenter(s):Edward Y. Woo, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
1:30 PM - 1:35 PM How To Treat Patients With Large AAAs Who Are Unfit For Open Repair In 2018: When Should They Undergo EVAR
  Presenter(s):Katariina M. Noronen, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
1:36 PM - 1:41 PM Why EVAR 2 Level 1 Evidence May Not Apply In 2018 And Why Patients Unfit For Open Repair May Now Benefit From EVAR
  Presenter(s):Cynthia K. Shortell, MD / Leila Mureebe, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
1:42 PM - 1:47 PM New Insights Into Long-Term Reintervention And AAA Rupture Rates After EVAR And Open Repair: From The SVS VQI
  Presenter(s):Philip P. Goodney, MD, MS  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
1:48 PM - 1:54 PM Panel Discussion
END OF SESSION 43
 
SESSION 44 SCHEDULE
Wednesday
SESSION 44: MORE NEW DEVELOPMENTS RELATING TO AAAs AND EVAR
Location: Trianon Ballroom, 3rd Floor
Moderators:Jan D. Blankensteijn, MD / Edward Y. Woo, MD  
x
1:54 PM - 1:59 PM The Gamesmanship And Subjectivity Involved In Measuring AAA Diameter: You Can Make It What You Want
  Presenter(s):Janet T. Powell, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
2:00 PM - 2:05 PM Significance Of Infrarenal Aortas Measuring 25-29 mm In Diameter: They Will Likely Become Aneurysmal And They Require Follow-Up: At What Intervals
  Presenter(s):Martin Bjorck, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
2:06 PM - 2:11 PM DEBATE: EVAR With Large Diameter Devices (Up To 36 mm) Can Be Effective And Are Associated With Acceptable Risks: Special Tips For Treatment
  Presenter(s):Michael J. Singh, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
2:12 PM - 2:17 PM DEBATE: Not So. Large Diameter AAA Necks And Devices Over 28 mm Have Higher EVAR Failure Rates: How Should They Be Treated
  Presenter(s):Ali F. AbuRahma, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
2:18 PM - 2:23 PM EVAR With Large Diameter Devices Have Increased Risks Of Failure: When Should Ch/EVAR Or F/EVAR Be Used Instead Of Standard EVAR With Large Diameter Devices
  Presenter(s):Jason T. Lee, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
2:24 PM - 2:29 PM How And When To Treat Thrombus Within Endografts And The Native Aorta
  Presenter(s):Barend M.E. Mees, MD, PhD / Geert Willem H. Schurink, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
2:30 PM - 2:36 PM Panel Discussion
2:36 PM - 2:41 PM Value And Limitations Of EVAR For Inflammatory AAAs And Other AAAs Of Rare Etiologies
  Presenter(s):Furuzan Numan, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
2:42 PM - 2:47 PM How Best To Treat Inflammatory AAAs: When Is EVAR Best And When Is It Not
  Presenter(s):Sonia Ronchey, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
2:48 PM - 2:53 PM What Is The Association Between AAAs, TBADs And Cancer: What Is It Due To
  Presenter(s):Natzi Sakalihasan, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
2:54 PM - 2:59 PM Bare Stent Suprarenal Fixation For EVAR: Is It Harmful Or Beneficial: What Are The Pros And Cons
  Presenter(s):Claude Mialhe, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
3:00 PM - 3:05 PM Fenestrated Iliac Limbs To Preserve Hypogastric Flow When IBDs Won’t Work: How To Obtain Them Or Make Them
  Presenter(s):Afshin Assadian, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
3:06 PM - 3:11 PM Do We Have The Right Endograft To Treat AAAs In Women: What Is The Best Device For EVAR In Women: Should Open Repair Be Used More
  Presenter(s):Sigrid Nikol, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
3:12 PM - 3:17 PM EVAR Explantation And Revascularization For Failure And Infection: Technical Tips And Results
  Presenter(s):Thomas C. Bower, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
3:18 PM - 3:23 PM Panel Discussion
3:24 PM - 3:30 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 44
 
SESSION 45 SCHEDULE
Wednesday
SESSION 45: CHALLENGING RECORDED LIVE CASES AND THOSE EMPLOYING INNOVATIVE TECHNIQUES
Location: Trianon Ballroom, 3rd Floor
Moderators:Plinio Rossi, MD / Andrew Holden, MBChB / Carlo Setacci, MD / Fabrizio Fanelli, MD, EBIR / Frank J. Veith, MD  
x
3:30 PM - 3:40 PM Internal Iliac Artery Preservation Using Parallel Grafts: Successes And Mistakes
  Presenter(s):Andrew Holden, MBChB  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
3:40 PM - 3:50 PM Hybrid Arterialization Of The Venous System Of The Foot In No Option CLI Patients
  Presenter(s):Roberto Ferraresi, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
3:50 PM - 4:00 PM Complex TAAA Endovascular Repair
  Presenter(s):Stephan Haulon, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
4:00 PM - 4:10 PM Retrograde BTK Micro-Stenting: Initial Experience
  Presenter(s):Marco G. Manzi, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
4:10 PM - 4:20 PM TEVAR: Step-By-Step
  Presenter(s):Dittmar Boeckler, MD  
Location: Trianon Ballroom, 3rd Floor
4:20 PM - 4:30 PM Treatment Of A Type 3B Endoleak With Off-Label Use Of A Device Used In Structural Heart Disease
  Presenter(s):Jos C. van den Berg, MD, PhD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
4:30 PM - 4:40 PM What Kind Of Drug Do We Need To Treat BTK Arteries In CLI Patients
  Presenter(s):Marianne Brodmann, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
END OF SESSION 45
 
SESSION 46 SCHEDULE
Wednesday
SESSION 46: RECORDED COMPLEX LIVE CASES FROM LEIPZIG AND LINC: PIONEERING TECHNIQUES FOR CHALLENGING VASCULAR PATHOLOGIES
Location: Trianon Ballroom, 3rd Floor
Moderators:Giancarlo Biamino, MD, PhD / Dierk Scheinert, MD  
x
4:40 PM - 5:00 PM Minimal Invasive Segmental Artery Coil Embolization (MISACE) For Prevention Of Spinal Cord Ischemia During EVAR Of Thoracoabdominal Aortic Pathologies: Initial Clinical Results
  Presenter(s):Daniela Branzan, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
4:50 PM - 5:00 PM Minimal Invasive Segmental Artery Coil Embolization (MISACE) For Prevention Of Spinal Cord Ischemia During EVAR Of Thoracoabdominal Aortic Pathologies: Initial Clinical Results: Technical Aspects
  Presenter(s):Andrej Schmidt, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
5:00 PM - 5:10 PM Experience With A New Nano-Coated DCB: 12-Month Results From The EFFPAC-RCT
  Presenter(s):Marcus Thieme, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
5:10 PM - 5:20 PM Recorded Case: Transluminal Tumescent Anesthesia During Angioplasty Of Severely Calcified Vessels
  Presenter(s):Andrej Schmidt, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
5:20 PM - 5:30 PM DCB + Focal scaffolding: The New Concept For Optimized BTK Angioplasty?
  Presenter(s):Marianne Brodmann, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
5:30 PM - 5:40 PM Recorded Case: DCB + Tack Scaffolds BTK
  Presenter(s):Andrej Schmidt, MD  
Location: Trianon Ballroom, 3rd Floor
5:40 PM - 5:50 PM Recorded Case: Prerecorded Percutaneous Deep Venous Arterialization: Procedure Using The LimFlow Technique
  Presenter(s):Steven Kum, MD  
Location: Trianon Ballroom, 3rd Floor
  View Slides in PDF      
END OF SESSION 46